FAKTOR OPTIONSSCHEIN - BAYER | Market Closed - Deutsche Boerse AG 15:50:13 2024-05-17 EDT | ||
| 1.5 EUR | -0.66% |
|
| Current month | -9.09% | ||
| 1 month | -17.58% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BAYER AG
| Date | Price | Change |
|---|---|---|
| 24-05-17 | 1.5 | -0.66% |
| 24-05-16 | 1.51 | +4.86% |
| 24-05-15 | 1.44 | +0.70% |
| 24-05-14 | 1.43 | 0.00% |
| 24-05-13 | 1.43 | -2.72% |
Delayed Quote Deutsche Boerse AG
Last update May 17, 2024 at 03:50 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BAYER AG |
| Issuer | 
BNP Paribas
|
| WKN | PF2BYS |
| ISIN | DE000PF2BYS1 |
| Date issued | 2019-06-28 |
| Strike | 28.65 € |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 2 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.74 € |
|---|---|
| Lowest since issue | 0.41 € |
| Spread | 0.04 € |
| Spread % | 2.58% |
Company Profile
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
-
Consensus: Bayer AG
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
28.58
EUR
Average target price
36.9
EUR
Spread / Average Target
+29.13%
- Stock Market
- Certificates
- Certificat
